April 4-7, 2018, Head of RUDN Department of Theory and History of International Relations, Assoc.prof. D.Degterev, PhD, took part in the 59th Convention of the International Studies Association in San Francisco, USA, delivering a report «Russia as an international donor: soviet legacy vs conventional pragmatism», attending several conference sessions, holding talks with scientific editors of the leading scientific publications of the world discussing publication of RUDN academics’ monographs.
The Association for International Studies was founded in 1959, and is one of the oldest interdisciplinary associations for the study of international, transnational and global problems. The Association brings together over 7,000 members from around the world, including academics, practitioners, policy experts, private sector workers and independent researchers. The 59th Convention Convention was the most numerous - about 5 thousand researchers took part in more than 1,300 sessions. The next convention will be held in March 2019, in Toronto, Canada.
A RUDN chemist has obtained a new compound — a dumbbell-shaped phosphate-bridged molybdenum cluster. The cluster accelerates the reaction of the formation of sulfides from oxides and can be used in pharmaceutical and cosmetic manufacturing.
Mathematicians from RUDN University have studied the properties of compositional operators in spaces with mixed Lebesgue norms. It will help describe the diffusion of liquids in materials with cracks and in porous materials. Such spaces are also useful for obtaining estimates for solutions to the Navier-Stokes equation.
A biophysicist from RUDN University and his colleagues modelled the molecular dynamics of growth of microtubules, the most important elements of cell activity. The researchers have built a model for the interaction of microtubule subunits, which takes into account their internal and external connections. The results will help form a more complete model of the dynamic instability of microtubules. It will allow choosing chemical agents for the treatment of certain diseases, including neoplasms and neurodegenerative pathologies.